Irreversible Pulpitis
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
SeptodontFrance - Saint-Maur-des-Fosses
1 programSelective Caries Removal with Biodentine™N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Alliance PharmaceuticalsBite Force Measurements
SeptodontSelective Caries Removal with Biodentine™
Clinical Trials (2)
Total enrollment: 361 patients across 2 trials
Bite Force Measurements
Start: May 2025Est. completion: Nov 2026112 patients
N/ARecruiting
Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy
Start: Apr 2021Est. completion: Sep 2025249 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 361 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.